Involvement of the Transforming Growth Factor &bgr; in the Pathogenesis of Hereditary Hemorrhagic Telangiectasia

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|10|1195-1200

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.10, 2006-04, pp. : 1195-1200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transforming Growth Factor-&bgr;: A Molecular Target for the Future Therapy of Glioblastoma

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 341-349

Bentham Science Publishers

Access to resources Recommend Favorite

Natural Products and Transforming Growth Factor-beta (TGF-&bgr;) Signaling in Cancer Development and Progression

By  

Current Cancer Drug Targets, Vol. 13, Iss. 5, 2013-06 ,pp. : 500-505

Bentham Science Publishers

Access to resources Recommend Favorite

Introduction: Hereditary Hemorrhagic Telangiectasia as a Rare Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1171-1172

Bentham Science Publishers

Access to resources Recommend Favorite

Transforming Growth Factor-&bgr;1 Induces Endothelin-1 in a Bovine Pulmonary Artery Endothelial Cell Line and Rat Lungs via cAMP

By Lee S.D.   Lee D.S.   Chun Y.G.   Paik S.H.   Kim W.S.   Kim D.S.   Kim W.D.   Tuder R.M.   Voelkel N.F.  

Pulmonary Pharmacology & Therapeutics, Vol. 13, Iss. 6, 2000-12 ,pp. : 257-265

Academic Press

Access to resources Recommend Favorite

Ablation of T-Helper 1 Cell Derived Cytokines and of Monocyte-Derived Tumor Necrosis Factor- in Hereditary Hemorrhagic Telangiectasia: Immunological Consequences and Clinical Considerations

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1201-1208

Bentham Science Publishers

Access to resources Recommend Favorite